<bill session="117" type="s" number="2486" updated="2023-08-02T19:15:23Z">
  <state datetime="2021-07-27">REFERRED</state>
  <status>
    <introduced datetime="2021-07-27"/>
  </status>
  <introduced datetime="2021-07-27"/>
  <titles>
    <title type="official" as="introduced">A bill to authorize the use of drugs, vaccines, and medical technologies to expand military and civilian access to such products and to improve transparency in taxpayer-funded biomedical research investments by the Department of Defense, and for other purposes.</title>
    <title type="display">Make Taxpayer-Funded Department of Defense Medical Interventions Affordable Act</title>
    <title type="short" as="introduced">Make Taxpayer-Funded Department of Defense Medical Interventions Affordable Act</title>
  </titles>
  <sponsor bioguide_id="W000817"/>
  <cosponsors/>
  <actions>
    <action datetime="2021-07-27">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-07-27" state="REFERRED">
      <text>Read twice and referred to the Committee on Armed Services.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSAS" name="Senate Armed Services" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="4757" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Armed forces and national security"/>
  </subjects>
  <amendments/>
  <summary date="2023-08-02T19:05:51Z" status="Introduced in Senate">Make Taxpayer-Funded Department of Defense Medical Interventions Affordable Act

This bill requires the Department of Defense (DOD) to report on its efforts to comply with provisions of a report related to the licensing of federally owned medical interventions. DOD must also compile into a searchable database information relating to federal support provided by DOD for biomedical research and development.</summary>
</bill>
